Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
392 participants
OBSERVATIONAL
2000-12-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Clinical Evaluation of ASR and ReCap Resurfacing Arthroplasty
NCT00249054
Evaluation of Weight Bearing After Total Hip and Knee Replacement
NCT01135160
A Comparison of Two Metal Surface Finishes on Femoral Components in Hip Arthroplasty
NCT00116038
Compaction Total Hip Arthroplasty (THA) Bilateral
NCT00317889
Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty
NCT00376610
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
THA. Bearing of Zirconia head and UHMWPE liner
THA
B
THA. Bearing of CO-Cr-Mo head and liner
THA
C
THA. Head og Zirconia head and UHMWPE moulded in shell (Asian)
THA
D
THA. Head and shell og Alumina ceramic
THA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
THA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Frederiksberg University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Arne Borgwardt
MD Head of Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arne Borgwardt, md
Role: PRINCIPAL_INVESTIGATOR
Frederiksberg UH
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KF-01-355/98
Identifier Type: -
Identifier Source: org_study_id
NCT00289692
Identifier Type: -
Identifier Source: nct_alias
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.